Defining secondary progressive multiple sclerosis

被引：0
|
作者：
Lorscheider, Johannes [1 ,2 ]
Buzzard, Katherine [1 ]
Jokubaitis, Vilija [2 ]
Spelman, Tim [2 ]
Lechner-Scott, Jeannette [3 ]
McCombe, Pam [4 ]
Vucic, Steve [5 ]
Barnett, Michael [6 ]
Butzkueven, Helmut [1 ,2 ,7 ]
Kalincik, Tomas [1 ,2 ]
机构：
[1] Royal Melbourne Hosp, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] John Hunter Hosp, Newcastle, NSW, Australia
[4] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[5] Westmead Hosp, Sydney, NSW, Australia
[6] Univ Sydney, Sydney, NSW 2006, Australia
[7] Box Hill Hosp, Melbourne, Vic, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷 / 14期
关键词：
Progressive multiple sclerosis clinical phenotypes;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
OP 9.1
引用
收藏
页码：NP15 / NP15
页数：1
相关论文
共 50 条
  • [41] Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis
    Theodorsdottir, Asta
    Larsen, Pia Veldt
    Nielsen, Helle Hvilsted
    Illes, Zsolt
    Ravnborg, Mads Henrik
    ACTA NEUROLOGICA SCANDINAVICA, 2022, 145 (03): : 332 - 347
  • [42] Which one is more progressive; Primary, or Secondary Progressive Multiple Sclerosis?
    Ozcelik, Sinem
    Kaya, Ergi
    Ozdogar, Asiye Tuba
    Ozakbas, Serkan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1247 - 1248
  • [43] Oral Masitinib in Patients with Primary Progressive or Secondary Progressive Multiple Sclerosis
    Vermersch, Patrick
    Benrabah, Rabah
    Schmidt, Nicolas
    Zephir, Helene
    Chen, Pierre
    Vongsouthi, Cyrille
    Moussy, Alain
    Hermine, Olivier
    NEUROLOGY, 2009, 72 (11) : A313 - A314
  • [44] Psychological functioning in primary progressive versus secondary progressive multiple sclerosis
    Vleugels, L
    Pfennings, L
    Pouwer, F
    Cohen, L
    Ketelaer, P
    Polman, C
    Lankhorst, G
    van der Ploeg, H
    BRITISH JOURNAL OF MEDICAL PSYCHOLOGY, 1998, 71 : 99 - 106
  • [45] Clinical and laboratory features of primary progressive and secondary progressive multiple sclerosis
    Bashir, K
    Layton, B
    Whatley, W
    Whitaker, JN
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 466 - 466
  • [46] Risk of transition to secondary progressive multiple sclerosis and accumulation of disability in progressive multiple sclerosis are not influenced by current therapies
    Alcala, C.
    Gascon, F.
    Perez-Miralles, F-C.
    Escutia, M.
    Coret, F.
    Casanova, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 702 - 702
  • [47] Defining the risk factors for the conversion to secondary progressive multiple sclerosis: a retrospective cohort study of the Italian MS Register
    Iaffaldano, P.
    Lucisano, G.
    Patti, F.
    Morra, V. Brescia
    De Luca, G.
    Lugaresi, A.
    Zaffaroni, M.
    Inglese, M.
    Salemi, G.
    Cocco, E.
    Millefiorini, E.
    Sola, P.
    Calgani, S.
    Bergamaschi, R.
    Pozzilli, C.
    Salvetti, M.
    Lus, G.
    Rovaris, M.
    Maniscalco, G. T.
    Logullo, F. O.
    Paolicelli, D.
    Achille, M.
    Aiello, M.
    Lovato, V.
    Comi, G.
    Amato, M. P.
    Trojano, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 54 - 55
  • [48] Mitoxantrone versus cyclophosphamide in secondary progressive multiple sclerosis
    Perini, P
    Calabrese, M
    Tiberio, M
    Laroni, A
    Battistin, L
    Gallo, P
    MULTIPLE SCLEROSIS, 2005, 11 : S171 - S171
  • [49] Identifying active secondary progressive multiple sclerosis (SPMS)
    Martin, Sarah-Jane
    Raufdeen, Fasna
    Marriott, James
    Oh, Jiwon
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 171 - 172
  • [50] Compromise of the cognitive functions in progressive secondary multiple sclerosis
    Andreu-Catala, M.
    Pascual-Lozano, A. M.
    Bueno-Cayo, A.
    Bosca-Blasco, I.
    Coret-Ferrer, F.
    Casanova-Estruch, B.
    REVISTA DE NEUROLOGIA, 2008, 46 (11) : 664 - 666
12345